Literature DB >> 3561893

Optimization of freezing, storage, and thawing conditions for the preparation of metabolically active synaptosomes from frozen rat and human brain.

P R Dodd, J A Hardy, E B Baig, A M Kidd, E D Bird, W E Watson, G A Johnston.   

Abstract

Samples of rat and human cerebral cortex were frozen, stored, and thawed under a variety of conditions to define further the optimal procedure for storing human brain samples for subsequent metabolic and functional studies that use incubated synaptosomes. Tissue samples were best preserved by immersing them in isotonic sucrose prior to slow freezing, but there was no advantage in first chopping up the material. High concentrations of sucrose, rather than exerting a cryoprotective effect, were detrimental to subsequent synaptosomal performance (oxygen uptake, K+ accumulation, stimulus-induced release of amino acid neurotransmitters). However, good activity was observed in preparations from rat brain frozen in the absence of fluid. This result was confirmed by studies on the uptake of gamma-aminobutyrate (GABA) into an osmotically sensitive compartment in synaptosomes prepared from frozen human autopsy material transshipped from the brain tissue collection ("brain bank") at Harvard Medical School, MA, USA, to Sydney, Australia. Although activity was slowly lost over a 3-mo period in rat tissue samples stored at -20 degrees C, there was little or no such loss at -70 degrees C.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3561893     DOI: 10.1007/BF02834357

Source DB:  PubMed          Journal:  Neurochem Pathol        ISSN: 0734-600X


  21 in total

1.  Electrically evoked synaptosomal amino acid transmitter release in human brain in alcohol misuse.

Authors:  Sheng-Wen Kuo; Peter R Dodd
Journal:  Neurosignals       Date:  2011-08-11

2.  Preferential accumulation of amyloid-beta in presynaptic glutamatergic terminals (VGluT1 and VGluT2) in Alzheimer's disease cortex.

Authors:  Sophie Sokolow; Sanh H Luu; Karabi Nandy; Carol A Miller; Harry V Vinters; Wayne W Poon; Karen H Gylys
Journal:  Neurobiol Dis       Date:  2011-09-03       Impact factor: 5.996

3.  Sex differences in NMDA receptor expression in human alcoholics.

Authors:  Justin P Ridge; Ada M-C Ho; Peter R Dodd
Journal:  Alcohol Alcohol       Date:  2009-09-07       Impact factor: 2.826

4.  Association of polymorphisms in RGS4 and expression of RGS transcripts in the brains of human alcoholics.

Authors:  Ada M-C Ho; Rachel K MacKay; Peter R Dodd; Joanne M Lewohl
Journal:  Brain Res       Date:  2010-04-27       Impact factor: 3.252

5.  Quantitation of the beta-bungarotoxin-induced release of lactate dehydrogenase from cerebrocortical synaptosomes.

Authors:  C Martinez; A Pérez-Martos; M J López Pérez
Journal:  Neurochem Res       Date:  1989-09       Impact factor: 3.996

6.  Flow Cytometry Analysis and Quantitative Characterization of Tau in Synaptosomes from Alzheimer's Disease Brains.

Authors:  Karen Hoppens Gylys; Tina Bilousova
Journal:  Methods Mol Biol       Date:  2017

7.  Apolipoprotein E/Amyloid-β Complex Accumulates in Alzheimer Disease Cortical Synapses via Apolipoprotein E Receptors and Is Enhanced by APOE4.

Authors:  Tina Bilousova; Mikhail Melnik; Emily Miyoshi; Bianca L Gonzalez; Wayne W Poon; Harry V Vinters; Carol A Miller; Maria M Corrada; Claudia Kawas; Asa Hatami; Ricardo Albay; Charles Glabe; Karen H Gylys
Journal:  Am J Pathol       Date:  2019-05-17       Impact factor: 4.307

8.  Benzodiazepine binding sites in alcoholic cirrhotics: evidence for gender differences.

Authors:  P R Dodd
Journal:  Metab Brain Dis       Date:  1995-03       Impact factor: 3.584

9.  The neurochemical pathology of thiamine deficiency: GABAA and glutamateNMDA receptor binding sites in a goat model.

Authors:  P R Dodd; G J Thomas; A McCloskey; D I Crane; I D Smith
Journal:  Metab Brain Dis       Date:  1996-03       Impact factor: 3.584

10.  Cortical NMDA receptor expression in human chronic alcoholism: influence of the TaqIA allele of ANKK1.

Authors:  Justin P Ridge; Peter R Dodd
Journal:  Neurochem Res       Date:  2009-03-13       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.